» Articles » PMID: 31676058

Genetic and Environmental Considerations for Inflammatory Bowel Disease

Overview
Specialty General Surgery
Date 2019 Nov 3
PMID 31676058
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease is a chronic inflammatory disorder of the gastrointestinal tract driven by an exaggerated immune response to luminal microbiota in susceptible individuals. It presents with a heterogenous pattern of clinical disease severity, location, and behavior. Understanding the interaction between the host genome, gut microbiome, and further environmental exposures in the development of IBD is in the early stages, and factors that trigger onset of disease in susceptible individuals remain unknown. This article addresses the genetic, microbial, and environmental influences on development of inflammatory bowel disease and the ability to manipulate these factors through surgery and medical therapy.

Citing Articles

The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis.

Hu X, Tang X, Li L, Luo L, He X, Yan Q BMC Gastroenterol. 2024; 24(1):406.

PMID: 39533176 PMC: 11555959. DOI: 10.1186/s12876-024-03480-9.


Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.

Verstockt B, Pivorunas V, Al Mahi N, Smaoui N, Guay H, Kennedy N J Crohns Colitis. 2023; 18(4):493-505.

PMID: 37801628 PMC: 11037103. DOI: 10.1093/ecco-jcc/jjad170.


Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea.

Kang G, Park S, Jung Y, Jee J, Kim M, Lee S Gut Liver. 2022; 16(5):775-785.

PMID: 35975640 PMC: 9474483. DOI: 10.5009/gnl210369.


Probiotics Interact With Lipids Metabolism and Affect Gut Health.

Wu T, Wang G, Xiong Z, Xia Y, Song X, Zhang H Front Nutr. 2022; 9:917043.

PMID: 35711544 PMC: 9195177. DOI: 10.3389/fnut.2022.917043.


Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire.

Ostromohov G, Fibelman M, Hirsch A, Ron Y, Cohen N, Kariv R United European Gastroenterol J. 2021; 10(1):104-114.

PMID: 34939350 PMC: 8830304. DOI: 10.1002/ueg2.12182.